Advancing Cervical Cancer Prevention Initiatives in Resource-Constrained Settings: Insights from the Cervical Cancer Prevention Program in Zambia

PLoS Medicine

Volumn 8, Issue 5, 2011, Pages

  Mwanahamuntu, Mulindi H ^a,b   Sahasrabuddhe, Vikrant V ^c   Kapambwe, Sharon ^a,b   Pfaendler, Krista S ^d   Chibwesha, Carla ^a,e   Mkumba, Gracilia ^a,b   Mudenda, Victor ^b   Hicks, Michael L ^f   Vermund, Sten H ^c   Stringer, Jeffrey S A ^a,e   Parham, Groesbeck P ^a,b,e  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Michigan Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL PROTOCOL; CONCEPTUAL FRAMEWORK; DIAGNOSTIC ACCURACY; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION TECHNOLOGY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PUBLIC HEALTH; UTERINE CERVIX CANCER; ZAMBIA; DEVELOPING COUNTRY; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; MEDICAL INFORMATICS; UTERINE CERVIX TUMOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DEVELOPING COUNTRIES; FEMALE; HEALTH PLAN IMPLEMENTATION; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICAL INFORMATICS; PROGRAM EVALUATION; UTERINE CERVICAL NEOPLASMS; ZAMBIA;

EID: 79958006251     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001032     Document Type: Article

References (20)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, et al. (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370: 398-406.
3. Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, et al. (2007) Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 196: 407 e401-408; discussion 407 e408-409.
4. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K, (2003) Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 361: 814-820.
5. Sankaranarayanan R, Boffetta P, (2010) Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol 21: 1935-1943.
6. Gakidou E, Nordhagen S, Obermeyer Z, (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 5: e132 doi:10.1371/journal.pmed.0050132.
7. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, et al. (2009) Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 23: N1-N5.
8. Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, et al. (2010) eC3-a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis 14: 167-173.
9. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, et al. (2006) Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022.
10. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, et al. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96: 1480-1483.
11. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, et al. (2010) Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Therapy 4: 713-722.
12. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, et al. (2008) Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol 110: 402-407.
13. Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, et al. (2010) Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot 17: 47-50.
14. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, et al. (2010) Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 376: 1186-1193.
15. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793.
16. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, et al. (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360: 1385-1394.
17. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Jr, (2010) Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 102: 1557-1567.
18. Trope LA, Chumworathayi B, Blumenthal PD, (2009) Preventing cervical cancer: stakeholder attitudes toward CareHPV-focused screening programs in Roi-et Province, Thailand. Int J Gynecol Cancer 19: 1432-1438.
19. Denny CC, Emanuel EJ, (2008) US health aid beyond PEPFAR: the Mother & Child Campaign. JAMA 300: 2048-2051.
20. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, et al. (2008) A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 9: 929-936.